封面
市场调查报告书
商品编码
1417876

3D 生物列印人体组织市场报告:2030 年趋势、预测与竞争分析

3D Bioprinted Human Tissue Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

3D 生物列印人体组织趋势与预测

到 2030 年,全球 3D 生物列印人体组织市场预计将达到 34 亿美元,2024 年至 2030 年复合年增长率为 7.8%。该市场的主要驱动因素是免疫细胞疗法的日益普及、技术进步以及对客製化 3D 列印、组织工程和器官替代的需求不断增长。全球3D生物列印人体组织市场的未来充满希望,在组织工程、整容手术、药物测试和开发以及食品测试市场方面存在机会。

3D 生物列印人体组织市场洞察

Lucintel 预测,由于临床试验应用的采用率不断提高,药物测试和开发预计将在预测期内呈现最高成长。

由于政府研发支出增加,预计北美将成为预测期内最大的地区。

常问问题

Q1.市场规模有多大?

A1. 到 2030 年,全球 3D 生物列印人体组织市场预计将达到 34 亿美元。

Q2.市场成长预测如何?

A2. 2024年至2030年,全球3D生物列印人体组织市场预计将以7.8%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些?

A3. 该市场的主要驱动力是免疫细胞疗法的日益增长、技术进步以及对定制 3D 列印、组织工程和器官替代的需求不断增长。

Q4.市场的主要细分市场是什么?

A4. 3D生物列印人体组织市场前景广阔,在组织工程、整容手术、药物测试和开发以及食品测试市场方面都有机会。

Q5.市场上主要企业有哪些?

A5. 3D生物列印人体组织的主要企业如下。

  • Organovo
  • Stratasys
  • 3D Systems
  • SOLS Systems
  • Youbionic

Q6.未来最大的细分市场是什么?

A6.Lucintel 预测,由于临床试验应用的采用率不断提高,药物测试和开发将在预测期内呈现最高增长。

Q7. 未来五年预计哪个地区将成为最大的市场?

A7. 由于政府研发支出增加,北美成为预测期内最大的地区。

Q8. 可以客製化报告吗?

A8. 是的,Lucintel 提供 10% 的客製化服务,无需额外付费。

目录

第一章执行摘要

第二章全球 3D 生物列印人体组织市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球3D生物列印人体组织市场趋势(2018-2023)与预测(2024-2030)
  • 全球 3D 生物列印人体组织市场(按应用)
    • 人体组织工程
    • 整容手术
    • 药物测试和开发
    • 食品检验
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球 3D 生物列印人体组织市场(按地区)
  • 北美3D生物列印人体组织市场
  • 欧洲3D生物列印人体组织市场
  • 亚太地区 3D 生物列印人体组织市场
  • 其他地区3D生物列印人体组织市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球 3D 生物列印人体组织市场成长机会(按应用)
    • 全球 3D 生物列印人体组织市场成长机会(按地区)
  • 全球3D生物列印人体组织市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球 3D 生物列印人体组织市场产能扩张
    • 全球3D生物列印人体组织市场的併购与合资企业
    • 认证和许可

第七章主要企业概况

  • Organovo
  • Stratasys
  • 3D Systems
  • SOLS Systems
  • Youbionic
简介目录

3D Bioprinted Human Tissue Trends and Forecast

The future of the global 3D bioprinted human tissue market looks promising with opportunities in the tissue engineering, cosmetic surgery, drug testing and development, and food testing markets. The global 3D bioprinted human tissue market is expected to reach an estimated $3.4 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing inclination towards immune cellular therapies, progress in technology, and rising demand for customized 3D printing, tissue engineering and organ replacement.

A more than 150-page report is developed to help in your business decisions.

3D Bioprinted Human Tissue by Segment

The study includes a forecast for the global 3D bioprinted human tissue by application and region.

3D Bioprinted Human Tissue Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Tissue Engineering
  • Cosmetic Surgery
  • Drug Testing and Development
  • Food Testing
  • Others

3D Bioprinted Human Tissue Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of 3D Bioprinted Human Tissue Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies 3D bioprinted human tissue companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the 3D bioprinted human tissue companies profiled in this report include-

  • Organovo
  • Stratasys
  • 3D Systems
  • SOLS Systems
  • Youbionic

3D Bioprinted Human Tissue Market Insights

Lucintel forecasts that drug testing and dvelopment is expected to witness the highest growth over the forecast period due to its increasing adoption in the clinical trial applications.

North America will reamin the largest region over the forecast period due to rising government R&D spending.

Features of the Global 3D Bioprinted Human Tissue Market

Market Size Estimates: 3D bioprinted human tissue market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: 3D bioprinted human tissue market size by application and region in terms of value ($B).

Regional Analysis: 3D bioprinted human tissue market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different applications and regions for the 3D bioprinted human tissue market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the 3D bioprinted human tissue market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the 3D bioprinted human tissue market size?

Answer: The global 3D bioprinted human tissue market is expected to reach an estimated $3.4 billion by 2030.

Q2. What is the growth forecast for 3D bioprinted human tissue market?

Answer: The global 3D bioprinted human tissue market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the 3D bioprinted human tissue market?

Answer: The major drivers for this market are increasing inclination towards immune cellular therapies, progress in technology, and rising demand for customized 3D printing, tissue engineering and organ replacement.

Q4. What are the major segments for 3D bioprinted human tissue market?

Answer: The future of the 3D bioprinted human tissue market looks promising with opportunities in the tissue engineering, cosmetic surgery, drug testing and development, and food testing markets.

Q5. Who are the key 3D bioprinted human tissue market companies?

Answer: Some of the key 3D bioprinted human tissue companies are as follows.

  • Organovo
  • Stratasys
  • 3D Systems
  • SOLS Systems
  • Youbionic

Q6. Which 3D bioprinted human tissue market segment will be the largest in future?

Answer: Lucintel forecasts that drug testing and dvelopment is expected to witness the highest growth over the forecast period due to its increasing adoption in the clinical trial applications.

Q7. In 3D bioprinted human tissue market, which region is expected to be the largest in next 5 years?

Answer: North America will reamin the largest region over the forecast period due to rising government R&D spending.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the 3D bioprinted human tissue market by application (tissue engineering, cosmetic surgery, drug testing and development, food testing, and others) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global 3D Bioprinted Human Tissue Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global 3D Bioprinted Human Tissue Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global 3D Bioprinted Human Tissue Market by Application
    • 3.3.1: Tissue Engineering
    • 3.3.2: Cosmetic Surgery
    • 3.3.3: Drug Testing and Development
    • 3.3.4: Food Testing
    • 3.3.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global 3D Bioprinted Human Tissue Market by Region
  • 4.2: North American 3D Bioprinted Human Tissue Market
  • 4.3: European 3D Bioprinted Human Tissue Market
    • 4.3.1: European 3D Bioprinted Human Tissue Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others
  • 4.4: APAC 3D Bioprinted Human Tissue Market
    • 4.4.1: APAC 3D Bioprinted Human Tissue Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others
  • 4.5: ROW 3D Bioprinted Human Tissue Market
    • 4.5.1: ROW 3D Bioprinted Human Tissue Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global 3D Bioprinted Human Tissue Market by Application
    • 6.1.2: Growth Opportunities for the Global 3D Bioprinted Human Tissue Market by Region
  • 6.2: Emerging Trends in the Global 3D Bioprinted Human Tissue Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global 3D Bioprinted Human Tissue Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global 3D Bioprinted Human Tissue Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Organovo
  • 7.2: Stratasys
  • 7.3: 3D Systems
  • 7.4: SOLS Systems
  • 7.5: Youbionic